SCHEMBL7398484

SCHEMBL7398484

O=C(O)C1(C(=O)O)[CH]C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10778290 0.73 CYP3A4 (0.32)
Hydrochloric Acid SCHEMBL8662463 0.71 CYP3A4 (0.31)
SCHEMBL2358074 0.69 HDAC4 (0.33)
SCHEMBL6177320 0.67
SCHEMBL5453204 0.66
SCHEMBL10776105 0.62
SCHEMBL17008406 0.54
Cyclohexane SCHEMBL27575916 0.51 CA1 (0.50)
Benzene SCHEMBL10964916 0.51 CA1 (0.71)
Benzene SCHEMBL10961254 0.51 CA1 (0.71)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104736140-A mGlu2/3 antagonists for the treatment of autistic disorders HOFFMANN LA ROCHE 2015-06-24 CN disclosed
EP-1255735-A2 PYRIDINE DERIVATIVES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2002-11-13 EP disclosed
EP-1189873-A1 EXCITATORY AMINO ACID RECEPTOR MODULATORS Lilly, S.A. (ES) 2002-03-27 EP disclosed
WO-2001056990-A2 PYRIDINE DERIVATES AS POTENTIATORS OF GLUTAMATE RECEPTORS ELI LILLY AND COMPANY (US) 2001-08-09 WO disclosed
WO-2000075101-A1 EXCITATORY AMINO ACID RECEPTOR MODULATORS LILLY, S.A. (ES) 2000-12-14 WO disclosed